LTRN
Lantern Pharma (LTRN)
$85
About Lantern Pharma (LTRN)
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Details
Daily high
$3.88
Daily low
$3.76
Price at open
$3.76
52 Week High
$5.74
52 Week Low
$1.11
Market cap
49.5M
Dividend yield
0.00%
Volume
37,509
Avg. volume
218,794
P/E ratio
-2.68
Lantern Pharma News
Details
Daily high
$3.88
Daily low
$3.76
Price at open
$3.76
52 Week High
$5.74
52 Week Low
$1.11
Market cap
49.5M
Dividend yield
0.00%
Volume
37,509
Avg. volume
218,794
P/E ratio
-2.68